Codes / ICD10CM / M05.339

M05.339 Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist

Summary

Rheumatoid heart disease with rheumatoid arthritis of unspecified wrist is a cardiac manifestation of rheumatoid arthritis (RA), an autoimmune disorder. It involves inflammation and damage to heart structures, such as the pericardium, myocardium, or endocardium, and occurs alongside rheumatoid arthritis affecting the wrist joint. This condition reflects systemic immune-mediated effects on the cardiovascular system.

Causes

The exact cause of rheumatoid heart disease is not fully understood. It is believed to result from chronic inflammation and immune dysregulation associated with rheumatoid arthritis, leading to tissue damage in the heart. Autoantibodies and inflammatory cytokines may contribute to cardiac involvement, though the precise mechanisms remain under investigation.

Risk Factors

  • Long-standing rheumatoid arthritis
  • High disease activity or severity of RA
  • Presence of rheumatoid factor (RF) or anti-citrullinated protein antibodies (ACPA)
  • Advanced age
  • Male gender (in some subtypes)

Symptoms

  • Chest pain or discomfort
  • Shortness of breath (dyspnea)
  • Fatigue
  • Palpitations
  • Swelling in the legs or abdomen (in severe cases)
  • Unexplained weight loss

Diagnosis

Diagnosis involves a combination of clinical evaluation, imaging, and laboratory tests. Echocardiography or cardiac MRI may identify structural or functional abnormalities. Laboratory tests for RA markers (e.g., RF, ACPA) and inflammatory markers (e.g., ESR, CRP) support the diagnosis. Clinical correlation with wrist arthritis symptoms is essential.

Treatment Options

Treatment focuses on managing rheumatoid arthritis and cardiac complications. Disease-modifying antirheumatic drugs (DMARDs) and biologics control systemic inflammation. Cardiac-specific therapies may include anti-inflammatory agents, diuretics, or medications for heart failure. Regular monitoring by rheumatology and cardiology specialists is recommended.

Prognosis and Follow-Up

Prognosis depends on disease severity, treatment response, and cardiac involvement. Early intervention with RA therapies can improve outcomes. Follow-up includes regular cardiac assessments (e.g., echocardiograms) and RA monitoring to detect complications early.

Complications

  • Heart failure
  • Pericarditis or pericardial effusion
  • Valvular heart disease
  • Arrhythmias
  • Increased risk of cardiovascular events (e.g., myocardial infarction, stroke)

Lifestyle & Prevention

  • Adhere to RA treatment plans to reduce systemic inflammation
  • Maintain a heart-healthy diet and regular exercise (as tolerated)
  • Avoid smoking, which worsens RA and cardiovascular risk
  • Monitor blood pressure and cholesterol levels
  • Attend scheduled medical appointments for RA and cardiac care

When to Seek Professional Help

Seek immediate care for chest pain, severe shortness of breath, or sudden swelling. Contact a healthcare provider for worsening RA symptoms (e.g., joint pain, stiffness) or new cardiac symptoms (e.g., palpitations, fatigue).

Tips for Medical Coders

Document the presence of rheumatoid arthritis affecting the wrist (unspecified) and cardiac involvement (e.g., pericarditis, myocarditis) to support code assignment. Ensure clinical correlation between RA and cardiac manifestations is clear in the medical record.

Book a walkthrough

M05.339 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.